FDA Drug recall D-0237-2021
HUMAN CHORIONIC GONADOTROPIN 1,250 IU per vial Aso contains Mannitol 9%, Sodium Phosphate 2% in water for injection
- FDA Drug
- Class II
- terminated
- Published 2021-01-27
On 2021-01-27 the FDA classified a Class II recall of HUMAN CHORIONIC GONADOTROPIN 1,250 IU per vial Aso contains Mannitol 9%, Sodium Phosphate 2% in water for injection by Complete Pharmacy And Medical Solutions, citing CGMP deviations: Lack of potency testing.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0237-2021 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2020-11-20 |
| Published | 2021-01-27 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Complete Pharmacy And Medical Solutions |
| Distribution | US |
Product
HUMAN CHORIONIC GONADOTROPIN 1,250 IU per vial Aso contains Mannitol 9%, Sodium Phosphate 2% in water for injection. Lyophilized, Unpreserved. Complete Pharmacy & Medical Solutions 5829 NW 158th St, Miami Lakes, FL 33014 Tel: 305-397-2035
Reason
CGMP deviations: Lack of potency testing.
Identifiers
| code_info | Lot #: 40548, Use By Date, 01/30/2021. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0237-2021%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.